Propanc: Funding, Investors & Team (Sep 2026)
Propanc is a company that conducts research and development to create therapies for cancer and other long-lasting illnesses. Their main focus is on crafting innovative treatments for patients with pancreatic, ovarian, and colorectal cancer.
Propanc has raised $103M across 2 funding rounds on record, the most recent an undisclosed round of $100M announced in Oct 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Propanc Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Propanc Funding Rounds
Propanc raised $2.6M in an undisclosed round announced in Aug 2025.
2 months later, an undisclosed round of $100M was announced in Oct 2025.
Propanc Founders and Leadership Team
No contact details are on record for this team yet.
Propanc Funding Compared to Other Biotechnology Startups
Propanc's latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Propanc in Biotechnology and Melbourne
Companies Similar to Propanc
AdvanCell is a company that focuses on developing innovative cancer treatments using alpha-emitting isotopes…
The objective of Fluent is to seamlessly integrate humans with AI, improving interaction and communication…
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's…
Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services…
Algenie was founded on a simple realization: algae has the potential to save the earth, but only if it is…
Paradigm Pharmaceuticals is a global biopharmaceutical company driven to discover, develop, and deliver…
Imugene is a publicly-listed biotechnology company with operations in America and Europe,
BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing…
Cauldron Ferm is a technique that speeds up the production of precision fermented prototypes to commercial…
HydGene Renewables is developing a biotechnology platform that produces on-site green hydrogen from waste…
Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more…
Propanc Funding FAQs
What does Propanc do?
Propanc is a company that conducts research and development to create therapies for cancer and other long-lasting illnesses. Their main focus is on crafting innovative treatments for patients with pancreatic, ovarian, and colorectal cancer.
How much funding has Propanc raised?
Propanc has raised $103M across 2 rounds on record. The most recent is an undisclosed round of $100M announced in Oct 2025.
When did Propanc last raise funding?
Propanc's most recent funding round on record is an undisclosed round of $100M, announced in Oct 2025.
Who founded Propanc?
FundedIQ lists Julian Kenyon (Founder) at Propanc.
Where is Propanc headquartered?
Propanc is based in Melbourne, Victoria, Australia.
How many employees does Propanc have?
Propanc is in the 1-10 employee band.
How does Propanc's funding compare to other Biotechnology startups?
Propanc's latest round of $100M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Propanc Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Propanc is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.